![](/img/cover-not-exists.png)
Crizotinib-resistant MET mutations in gastric cancer patients are sensitive to type II tyrosine kinase inhibitors
Shen, Bo, Wu, Feixiang, Ye, Jiazhou, Liang, Rong, Wang, Ruping, Yu, Ruoying, Wu, Xue, Shao, Yang W, Feng, JifengLanguage:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2019-0140
Date:
July, 2019
File:
PDF, 3.70 MB
english, 2019